Co-Authors
This is a "connection" page, showing publications co-authored by Nathan Peiffer-Smadja and François-Xavier Lescure.
Connection Strength
2.747
-
Challenges and issues about organizing a hospital to respond to the COVID-19 outbreak: experience from a French reference centre. Clin Microbiol Infect. 2020 Jun; 26(6):669-672.
Score: 0.876
-
High-dose daptomycin in patients with infective endocarditis or sternal wound infections. Clin Microbiol Infect. 2018 10; 24(10):1106-1108.
Score: 0.771
-
Clinical trial protocols of repurposed prophylaxis for COVID-19: A review. Infect Dis Now. 2021 02; 51(1):7-13.
Score: 0.227
-
Anticovid, a comprehensive open-access real-time platform of registered clinical studies for COVID-19. J Antimicrob Chemother. 2020 09 01; 75(9):2708-2710.
Score: 0.225
-
Type 1 interferons as a potential treatment against COVID-19. Antiviral Res. 2020 06; 178:104791.
Score: 0.219
-
Re: 'Determinants of in-hospital antibiotic prescription behaviour' by Lambregts et al. Clin Microbiol Infect. 2019 05; 25(5):635-637.
Score: 0.200
-
An open-label randomized controlled trial of the effect of lopinavir/ritonavir, lopinavir/ritonavir plus IFN-ß-1a and hydroxychloroquine in hospitalized patients with COVID-19. Clin Microbiol Infect. 2021 Dec; 27(12):1826-1837.
Score: 0.059
-
Corrigendum to "Review of trials currently testing treatment and prevention of COVID-19" [Clin Microbiol Infect 26.8 (2020) 988-998]. Clin Microbiol Infect. 2021 Mar; 27(3):499.
Score: 0.058
-
Assessment of Air Contamination by SARS-CoV-2 in Hospital Settings. JAMA Netw Open. 2020 12 01; 3(12):e2033232.
Score: 0.057
-
Review of trials currently testing treatment and prevention of COVID-19. Clin Microbiol Infect. 2020 Aug; 26(8):988-998.
Score: 0.055